-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Oral and Poster Abstracts
Saturday, December 5, 2015
7:30 AM-9:00 AM
Disorders of Platelet Number or Function
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
Health Services and Outcomes Research – Non-Malignant Conditions
9:30 AM-11:00 AM
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Myeloproliferative Syndromes: Clinical
Clinical Allogeneic Transplantation: Results
12:00 PM-1:30 PM
Hemoglobinopathies, Excluding Thalassemia – Clinical
Disorders of Platelet Number or Function
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Myelodysplastic Syndromes – Clinical Studies
Adoptive Immunotherapy
2:00 PM-3:30 PM
Disorders of Platelet Number or Function
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
4:00 PM-5:30 PM
Blood Coagulation and Fibrinolytic Factors
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Chronic Myeloid Leukemia: Therapy
Myelodysplastic Syndromes – Basic and Translational Studies
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
Clinical Allogeneic Transplantation: Results
5:30 PM-7:30 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Regulation of Iron Metabolism
Thalassemia and Globin Gene Regulation
Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science
Hemoglobinopathies, Excluding Thalassemia – Clinical
Granulocytes, Monocytes and Macrophages
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Platelet Activation and Biochemistry
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
Disorders of Platelet Number or Function
Blood Coagulation and Fibrinolytic Factors
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Antithrombotic Therapy
Basic Science and Clinical Practice in Blood Transfusion
Hematopoietic Stem and Progenitor Biology
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Bone Marrow Failure
Chromosomal Rearrangements and DNA Repair
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Clinical Studies
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes – Basic and Translational Studies
Myelodysplastic Syndromes – Clinical Studies
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Malignant Stem and Progenitor Cells
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
Adoptive Immunotherapy
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Clinical Autologous Transplantation: Results
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research – Non-Malignant Conditions
Health Services and Outcomes Research – Malignant Diseases
Sunday, December 6, 2015
7:30 AM-9:00 AM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Chromosomal Rearrangements and DNA Repair
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Myeloma: Therapy, excluding Transplantation
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
9:30 AM-11:00 AM
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Blood Coagulation and Fibrinolytic Factors
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
9:30 AM-11:15 AM
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
12:00 PM-1:30 PM
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
Hematopoietic Stem and Progenitor Biology
Acute Lymphoblastic Leukemia: Clinical Studies
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Gene Therapy and Transfer
Health Services and Outcomes Research – Malignant Diseases
4:30 PM-6:00 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Disorders of Coagulation or Fibrinolysis
Bone Marrow Failure
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases
Acute Myeloid Leukemia: Clinical Studies
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myelodysplastic Syndromes – Basic and Translational Studies
CLL: Biology and Pathophysiology, excluding Therapy
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Autologous Transplantation: Results
Clinical Allogeneic Transplantation: Results
6:00 PM-8:00 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Regulation of Iron Metabolism
Thalassemia and Globin Gene Regulation
Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science
Hemoglobinopathies, Excluding Thalassemia – Clinical
Granulocytes, Monocytes and Macrophages
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Platelet Activation and Biochemistry
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
Disorders of Platelet Number or Function
Blood Coagulation and Fibrinolytic Factors
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Antithrombotic Therapy
Basic Science and Clinical Practice in Blood Transfusion
Hematopoietic Stem and Progenitor Biology
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Bone Marrow Failure
Chromosomal Rearrangements and DNA Repair
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Clinical Studies
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes – Basic and Translational Studies
Myelodysplastic Syndromes – Clinical Studies
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Malignant Stem and Progenitor Cells
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
Adoptive Immunotherapy
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Clinical Autologous Transplantation: Results
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research – Non-Malignant Conditions
Health Services and Outcomes Research – Malignant Diseases
Monday, December 7, 2015
7:00 AM-8:30 AM
Regulation of Iron Metabolism
Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science
Platelet Activation and Biochemistry
Blood Coagulation and Fibrinolytic Factors
Antithrombotic Therapy
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases
Acute Myeloid Leukemia: Clinical Studies
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Basic Science
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Cell Collection and Processing
Clinical Autologous Transplantation: Results
Health Services and Outcomes Research – Non-Malignant Conditions
Health Services and Outcomes Research – Malignant Diseases
10:30 AM-12:00 PM
Regulation of Iron Metabolism
Hemoglobinopathies, Excluding Thalassemia – Clinical
Disorders of Coagulation or Fibrinolysis
Oncogenes and Tumor Suppressors
Acute Myeloid Leukemia: Clinical Studies
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes – Clinical Studies
CLL: Biology and Pathophysiology, excluding Therapy
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Health Services and Outcomes Research – Non-Malignant Conditions
Health Services and Outcomes Research – Malignant Diseases
2:45 PM-4:15 PM
Thalassemia and Globin Gene Regulation
Granulocytes, Monocytes and Macrophages
Pathophysiology of Thrombosis
Basic Science and Clinical Practice in Blood Transfusion
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Bone Marrow Failure
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
Myelodysplastic Syndromes – Basic and Translational Studies
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Health Services and Outcomes Research – Non-Malignant Conditions
4:30 PM-6:00 PM
Thalassemia and Globin Gene Regulation
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Basic Science and Clinical Practice in Blood Transfusion
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
Myeloproliferative Syndromes: Clinical
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Malignant Stem and Progenitor Cells
Adoptive Immunotherapy
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research – Malignant Diseases
Health Services and Outcomes Research – Malignant Diseases
6:00 PM-8:00 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Regulation of Iron Metabolism
Thalassemia and Globin Gene Regulation
Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science
Hemoglobinopathies, Excluding Thalassemia – Clinical
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Platelet Activation and Biochemistry
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
Disorders of Platelet Number or Function
Blood Coagulation and Fibrinolytic Factors
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Basic Science and Clinical Practice in Blood Transfusion
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Bone Marrow Failure
Chromosomal Rearrangements and DNA Repair
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Clinical Studies
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes – Basic and Translational Studies
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Malignant Stem and Progenitor Cells
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
Adoptive Immunotherapy
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research – Non-Malignant Conditions
Health Services and Outcomes Research – Malignant Diseases
6:15 PM-7:45 PM
Granulocytes, Monocytes and Macrophages
Antithrombotic Therapy
Hematopoietic Stem and Progenitor Biology
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Myelodysplastic Syndromes – Clinical Studies
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Clinical Autologous Transplantation: Results
